Terms: = Lung cancer AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta AND Staging
1 results:
1. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.
Jiang M; Wu C; Zhang L; Sun C; Wang H; Xu Y; Sun H; Zhu J; Zhao W; Fang Q; Yu J; Chen P; Wu S; Zheng Z; He Y; Zhou C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006632
[TBL] [Abstract] [Full Text] [Related]
